Emily Slotkin, MD

Trials

Studies that name Emily Slotkin, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:42 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT05275426 · A Study of LY2880070 and Gemcitabine in People With Ewing Sarcoma,Ewing-Like Sarcoma, and Desmoplastic Small Round Cell Tumor

  Memorial Sloan Kettering Cancer Center · completed · Ewing Sarcoma, Ewing-Like Sarcoma · principal investigator
• Ph1/Ph2
  NCT05004116 · A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer

  Memorial Sloan Kettering Cancer Center · recruiting · Advanced Cancer, Metastatic Solid Tumor · principal investigator
• N/A
  NCT04690374 · Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor

  Memorial Sloan Kettering Cancer Center · recruiting · Desmoplastic Small Round Cell Tumor · principal investigator
• N/A
  NCT04571229 · Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma

  Memorial Sloan Kettering Cancer Center · available · Osteosarcoma · principal investigator
• Ph1/Ph2
  NCT04095221 · A Study of the Drugs Prexasertib, Irinotecan, and Temozolomide in People With Desmoplastic Small Round Cell Tumor and Rhabdomyosarcoma

  Memorial Sloan Kettering Cancer Center · completed · Desmoplastic Small Round Cell Tumor, Rhabdomyosarcoma · principal investigator
• Ph2
  NCT04022213 · A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum

  Memorial Sloan Kettering Cancer Center · active not recruiting · Desmoplastic Small Round Cell Tumor, Peritoneal Cancer, Peritoneal Carcinoma · principal investigator
• Ph2
  NCT01864109 · Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma

  Memorial Sloan Kettering Cancer Center · active not recruiting · Newly Diagnosed Ewing Sarcoma · principal investigator
• Early Ph1
  NCT01189643 · Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor

  Memorial Sloan Kettering Cancer Center · active not recruiting · Sarcoma, Desmoplastic Small Round Cell Tumor (DSRCT) · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 05:42 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.